Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice
Diane Ly, Anjila Dongol, Peter Cuthbertson, et al.
Purinergic Signalling (2020) Vol. 16, Iss. 1, pp. 109-122
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Péter Illés
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5996-5996
Open Access | Times Cited: 102
Impact of NQO1 dysregulation in CNS disorders
Yuhan Li, Maryam Khaleghi Ghadiri, Ali Gorji
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases
Francesco Calzaferri, Cristina Ruiz‐Ruiz, Antonio M. G. de Diego, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 6, pp. 2427-2465
Open Access | Times Cited: 57
A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists
Simran Soni, Mihir S. Lukhey, Baban S. Thawkar, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 4643-4656
Closed Access | Times Cited: 7
P2X7 receptors drive poly(I:C) induced autism-like behavior in mice
Gergely Horváth, Lilla Otrokocsi, Katinka Bekő, et al.
Journal of Neuroscience (2019), pp. 1895-18
Open Access | Times Cited: 49
P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches
Paul R. Territo, Hamideh Zarrinmayeh
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 37
Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders
Xiaoming Liu, Yiwen Li, Liting Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis
Cristina Ruiz‐Ruiz, Francesco Calzaferri, Antonio G. Garcı́a
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 35
Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation
Francesco Calzaferri, Paloma Narros‐Fernández, Ricardo de Pascual, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 4, pp. 2272-2290
Open Access | Times Cited: 24
Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases
AbigailS Hackam, AndreaN Nortey, KimberlyN Garces
Neural Regeneration Research (2022) Vol. 17, Iss. 10, pp. 2149-2149
Open Access | Times Cited: 17
Chronic administration of P2X7 receptor antagonist JNJ-47965567 delays disease onset and progression, and improves motor performance in ALS SOD1G93A female mice
Cristina Ruiz‐Ruiz, Nuria García‐Magro, Pilar Negredo, et al.
Disease Models & Mechanisms (2020) Vol. 13, Iss. 10
Open Access | Times Cited: 27
P2X7 receptor antagonism increases regulatory T cells and reduces clinical and histological graft-versus-host disease in a humanised mouse model
Peter Cuthbertson, Nicholas J. Geraghty, Sam Adhikary, et al.
Clinical Science (2021) Vol. 135, Iss. 3, pp. 495-513
Open Access | Times Cited: 21
Androgen receptor antagonism accelerates disease onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis
Victoria M. McLeod, Chew L. Lau, Mathew D. F. Chiam, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 13, pp. 2111-2130
Open Access | Times Cited: 24
Ligand-receptor interactions: A key to understanding microglia and astrocyte roles in epilepsy
Peravina Thergarajan, Terence J. O’Brien, Nigel C. Jones, et al.
Epilepsy & Behavior (2024) Vol. 163, pp. 110219-110219
Open Access | Times Cited: 2
CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1G93A mice with a C57BL/6 background
Jeremy S. Lum, Mikayla Brown, Natalie E. Farrawell, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Novel P2X7 Antagonist Ameliorates the Early Phase of ALS Disease and Decreases Inflammation and Autophagy in SOD1-G93A Mouse Model
Savina Apolloni, Paola Fabbrizio, Susanna Amadio, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10649-10649
Open Access | Times Cited: 17
P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons
Rachael Bartlett, Diane Ly, Neil R. Cashman, et al.
Purinergic Signalling (2022) Vol. 18, Iss. 4, pp. 451-467
Open Access | Times Cited: 11
Agonists, Antagonists, and Modulators of P2X7 Receptors
Christa E. Müller, Vigneshwaran Namasivayam
Methods in molecular biology (2022), pp. 31-52
Closed Access | Times Cited: 10
Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis
Cinzia Volonté, Susanna Amadio, Francesco Liguori, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 14
Purinergic P2X7 Receptor: A Therapeutic Target in Amyotrophic Lateral Sclerosis
André D. J. McKenzie, Taylor R. Garrett, Eryn L. Werry, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 10, pp. 1479-1490
Closed Access | Times Cited: 8
Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis
Cinzia Volonté, Susanna Amadio
Neuropharmacology (2022) Vol. 221, pp. 109278-109278
Closed Access | Times Cited: 8
P2X7 receptors: a bibliometric review from 2002 to 2023
Haiting Tang, Wei Wei, Yu Luo, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 1
P2X7 regulates ependymo-radial glial cell proliferation in adult Danio rerio following spinal cord injury
Eva E. Stefanova, Julian Vincent T. Dychiao, Mavis C. Chinn, et al.
Biology Open (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 1
6-Furopyridine Hexamethylene Amiloride Is a Non-Selective P2X7 Receptor Antagonist
Peter Cuthbertson, Amal Elhage, Dena Al-Rifai, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1309-1309
Open Access | Times Cited: 7
P2X Receptor-Dependent Modulation of Mast Cell and Glial Cell Activities in Neuroinflammation
Barbora Salcman, Karen Affleck, Silvia Bulfone‐Paus
Cells (2021) Vol. 10, Iss. 9, pp. 2282-2282
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top